Post-Approval Study Protocol of the St. Jude Medical Trifecta Valve

NCT ID: NCT01514162

Last Updated: 2019-02-15

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

245 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-02-29

Study Completion Date

2014-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To further evaluate the long term clinical safety and effectiveness of the Trifecta valve

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To further evaluate the long term clinical safety and effectiveness of the Trifecta valve in subjects who had a Trifecta valve implanted during the IDE study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Valve Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Trifecta Valve Group

Subjects implanted with a Trifecta valve.

Group Type EXPERIMENTAL

Trifecta valve

Intervention Type DEVICE

surgical replacement of aortic valve

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Trifecta valve

surgical replacement of aortic valve

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects implanted with a Trifecta valve at one of the US sites of the IDE study.
* Subject met eligibility criteria of IDE study
* Subject agrees to complete study follow-up visits
* Subject provides written informed consent

Exclusion Criteria

* Subject currently participating in another device or drug study
* Subject unable or unwilling to return for study follow-up visits
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Abbott Medical Devices

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Abbott Northwestern Hospital Cardiac Surgical Associates

Minneapolis, Minnesota, United States

Site Status

Mayo Clinic

Rochester, Minnesota, United States

Site Status

Mission Hospital

Asheville, North Carolina, United States

Site Status

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, United States

Site Status

Vanderbilt Heart Institute

Nashville, Tennessee, United States

Site Status

Intermountain Heart & Lung Surgical Associates

Murray, Utah, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.